Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 95 filers reported holding Y-MABS THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $179 | +132.5% | 26,224 | +85.6% | 0.00% | 0.0% |
| Q3 2023 | $77 | -57.2% | 14,126 | -46.7% | 0.00% | 0.0% |
| Q2 2023 | $180 | -100.0% | 26,500 | +52.3% | 0.00% | -85.7% |
| Q3 2021 | $497,000 | -13.6% | 17,399 | +2.3% | 0.01% | +16.7% |
| Q2 2021 | $575,000 | +161.4% | 17,000 | +233.7% | 0.01% | 0.0% |
| Q2 2020 | $220,000 | – | 5,094 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 2,194,278 | $84,238,000 | 6.25% |
| Burrage Capital Management LLC | 123,025 | $4,723,000 | 3.73% |
| MPM BioImpact LLC | 337,291 | $12,949,000 | 3.12% |
| First Light Asset Management, LLC | 608,193 | $23,349,000 | 2.39% |
| Cormorant Asset Management, LP | 1,397,700 | $53,658,000 | 2.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 396,521 | $15,222,000 | 1.50% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 801 | $33,000 | 0.61% |
| Artal Group S.A. | 285,028 | $10,942,000 | 0.27% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 298,213 | $11,448,000 | 0.24% |
| Virtus ETF Advisers LLC | 7,309 | $281,000 | 0.15% |